These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32291550)

  • 1. A clinical audit of oral anticoagulant therapy in aged care residents with atrial fibrillation.
    Bernaitis N; Bowden M; La Caze A
    Int J Clin Pharm; 2020 Apr; 42(2):474-481. PubMed ID: 32291550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia.
    Rathinam I; Anoopkumar-Dukie S; Badrick T; Teasdale T; Bernaitis N
    Heart Lung Circ; 2020 Sep; 29(9):e222-e230. PubMed ID: 32291155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude.
    Bahri O; Roca F; Lechani T; Druesne L; Jouanny P; Serot JM; Boulanger E; Puisieux F; Chassagne P
    J Am Geriatr Soc; 2015 Jan; 63(1):71-6. PubMed ID: 25597559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-vitamin K antagonist oral anticoagulant (NOAC) use and dosing in Canadian practice: Insights from the optimising pharmacotherapy in the management approach to lowering risk in atrial fibrillation (OPTIMAL AF) Programme.
    Leblanc K; Bell AD; Ezekowitz JA; Tan MK; Laflamme D; Goldin L; Habert J; Lin PJ; Saunders K; Ngui D; Ng AP; Desroches J; Goodman SG;
    Int J Clin Pract; 2020 Dec; 74(12):e13625. PubMed ID: 33448547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.
    Saczynski JS; Sanghai SR; Kiefe CI; Lessard D; Marino F; Waring ME; Parish D; Helm R; Sogade F; Goldberg R; Gurwitz J; Wang W; Mailhot T; Bamgbade B; Barton B; McManus DD
    J Am Geriatr Soc; 2020 Jan; 68(1):147-154. PubMed ID: 31574165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention.
    Virdee MS; Stewart D
    Int J Clin Pharm; 2017 Feb; 39(1):173-180. PubMed ID: 28050712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation in atrial fibrillation in the elderly: the geriatrician point of view with a focus on the direct oral anticoagulants].
    Vogel T; Geny B; Kaltenbach G; Lang PO
    Rev Med Interne; 2015 Jan; 36(1):22-30. PubMed ID: 25234463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study.
    Blacher J; Sorbets E; Guedj Meynier D; Huberman JP; Gauthier J; Cohen S; Hoffman O
    Clin Drug Investig; 2019 Sep; 39(9):891-898. PubMed ID: 31183629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gap between indicated and prescribed stroke prevention therapies in a high-risk geriatric population.
    Shurrab M; Crystal E; O'Donnell D; Navare H; Neves P; Khatib R; Lashevsky I; Newman D
    J Interv Card Electrophysiol; 2017 Apr; 48(3):261-266. PubMed ID: 28091833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Cadogan SL; Powell E; Wing K; Wong AY; Smeeth L; Warren-Gash C
    Heart; 2021 Dec; 107(23):1898-1904. PubMed ID: 34645643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geriatric Conditions Are Associated With Decreased Anticoagulation Use in Long-Term Care Residents With Atrial Fibrillation.
    Zhang N; Patel J; Chen Z; Zhou Y; Crawford S; McManus DD; Gurwitz J; Shireman TI; Kapoor A
    J Am Heart Assoc; 2021 Aug; 10(16):e021293. PubMed ID: 34387127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation.
    Shurrab M; Ko DT; McElhaney J; Henderson M; Danon A; Quinn KL; O'Donnell D; Crystal E; Newman D
    J Am Med Dir Assoc; 2019 Aug; 20(8):984-987. PubMed ID: 30853427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.